Kinnate Biopharma Inc. KNTE
2.65 +2.65
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 121.18M | 118.52M | 90.11M | 36.00M | 12.01M | |
| 90.77M | 88.15M | 67.17M | 29.24M | 8.96M | |
| 28.24M | 30.37M | 22.95M | 6.76M | 3.06M | |
| -121.18M | -118.52M | -90.11M | -36.00M | -12.01M | |
| -112.65M | -116.27M | -89.76M | -35.76M | -11.97M | |
| -112.65M | -116.27M | -89.76M | -35.76M | -9.94M | |
| -112.65M | -116.27M | -89.76M | -35.76M | -9.94M | |
| -112.65M | -116.27M | -89.76M | -35.76M | -11.97M | |
| -2.42 | -2.64 | -2.06 | -5.28 | -2.72 | |
| -2.42 | -2.64 | -2.06 | -5.28 | -2.72 | |
| -2.42 | -2.64 | -2.06 | -5.28 | -2.72 | |
| -112.65M | -116.27M | -89.76M | -35.76M | -11.97M | |
| -112.65M | -116.27M | -89.76M | -35.76M | -11.97M | |
| 46.58M | 44.07M | 43.60M | 6.77M | 3.66M | |
| 46.58M | 44.07M | 43.60M | 6.77M | 3.66M |